Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extragonadal Effects of hCG on Calcium Homeostasis
NCT03418896Phase 1Completed
- Start
- Jan 2018
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of human chorionic gonadotropin in Hypogonadism. Primary endpoint: Serum calcium at 120 hours. Started Jan 2018; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03418896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418896.